During the past decade, Clinique Du Docteur Calabet; Cromg conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Du Docteur Calabet; Cromg" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Du Docteur Calabet; Cromg" are "Breast Cancer" (3 trials), "Ovarian Cancer" (2 trials), "Bladder Disease" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Clinique Du Docteur Calabet; Cromg" in a lesser frequency.

Most popular intervention types in "Clinique Du Docteur Calabet; Cromg" are "Drug" (6 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (2 trials), "Atezolizumab" (1 trials), "Toxicity : Time to progression, 1 and 2 years survival" (1 trials), "Yondelis®-Caelyx®" (1 trials) and "capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Du Docteur Calabet; Cromg" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Du Docteur Calabet; Cromg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Clinique Du Docteur Calabet; Cromg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Du Docteur Calabet; Cromg, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".